Jeremy Shepler in

Jeremy Shepler

Inspirer · DISC type di
Vice president, Global Commercial Leader, Immunology at Johnson & Johnson Innovative Medicine
📍 New York City Metropolitan Area, United States

Jeremy Shepler is the Vice President and Global Commercial Leader for Immunology at Johnson & Johnson. He is a seasoned marketer with a history of executing successful pre-commercialization and product marketing strategies. He attended Bentley University for his Bachelor of Science.

He is known for leading the commercialization of Ozempic at Novo Nordisk, guiding it to become the fastest chronic disease product to achieve blockbuster status.

Read the full overview →
Experience
13 Years
Current Role
Vice president, Global Commercial Leader, Immunology
Job Level
Senior
Location
New York City Metropolitan Area, United States
Personality Overview

How Jeremy shows up

Decisive
Achievment Oriented
Charming & Persuasive

They respond well to objective pitches but also attach some value to relationships. They measure a product on its merit but can be influenced by strong testimonials. They don’t mind taking a stand if they believe in something.

Priorities

Topics Jeremy cares about

Pharma Commercialization
He has a multifaceted career developing and executing pre-commercialization plans, most notably leading the Ozempic launch to become a blockbuster faster than any other chronic disease product.
Go-to-Market Strategy
He has developed and implemented comprehensive go-to-market strategies at multiple companies, including Galderma and Bryn Pharma, resulting in increased brand visibility and revenue.
+5 more topics Login to view topics
Career

Work history

9-2025
Vice president, Global Commercial Leader, Immunology
Johnson & Johnson Innovative Medicine
6-2024 - 9-2025
Vice president, Marketing Aesthetics
Galderma
5-2023 - 6-2024
SVP Sales and Marketing
Bryn Pharma
1-2023 - 5-2023
Vice President, Area Commerical Lead—East | Cardiometabolic Sales
Novo Nordisk
5-2022 - 5-2023
VP Cardiometabolic Portfolio Strategy and Commercialization
Novo Nordisk
In the press

Media appearances

Spill the tea on Jeremy Shepler - he's now at Galderma. Featured in Cafepharma Message Boards
See now
Education
2014 - 2014
Executive leadership program
The Wharton School
1996 - 2000
Bachelor of Science (B.S.)
Bentley University
Social presence
in
Behavioral profile

DISC profile (public)

d

Dominance (D)

Dominance (D) reflects how goal and task oriented a person is, and their ability to accomplish results irrespective of how demanding the circumstances might be. Those scoring high tend to be motivated by winning, competition, and success.

Other Johnson & Johnson Innovative Medicine Employees

Explore more public profiles from related professionals.

Chris Makarus
Chris Makarus
Product Marketing Manager
Johnson & Johnson Innovative Medicine
 Greg Pettis, MBA
Greg Pettis, MBA
National Account Director
Johnson & Johnson Innovative Medicine
 Lisa Miller
Lisa Miller
Associate Director, Pipeline Patient Experience
Johnson & Johnson Innovative Medicine
 Pallavi Bhuyan McElroy, PhD
Pallavi Bhuyan McElroy, PhD
Scientific Sr. Manager
Johnson & Johnson Innovative Medicine

More profiles

Discover additional public profiles from our index.

ID
Ibrahim Dogus
Mayor
London Borough of Lambeth
 Katherine Plommer
Katherine Plommer
Educational Consultant
Zaner-Bloser
 Tara .I. Gbolade
Tara .I. Gbolade
Member Board of Trustees
UK Green Building Council (UKGBC)
CM
Chris Mansfield
Head of Procurement and Cost Control
Hilton Hotels Corporation
Unlock the full playbookSee exactly how to sell to Jeremy. Free, 10 seconds.